Indivior Pharmaceuticals ($INDV) Insider Trading & Smart Money Activity

Indivior Pharmaceuticals, Inc. · Drug Manufacturers - Specialty & Generic · Latest filing Jun 22, 2026

Indivior Pharmaceuticals, Inc. ($INDV) has 4 insider trades and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($1.41M), net -$1.41M.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 1
Net insider $ (12 mo): -$1.41M
Congress trades (12 mo): 0
13F moves on file: 0
Analyst ratings on file: 1

INDV insider buying and selling by quarter

Quarter	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0 / 0	0 / 0
Q2 2026	2 · $1.41M	0 / 0	0 / 0
Q3 2026	0	0 / 0	0 / 0
Q4 2026	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All INDV insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
Jun 22, 2026	Insider	Joseph CiaffoniChief Executive Officer	Sell (Tax withholding)	612.55K sh	$23.47M	+7.7%	+5.6%	—
Jun 22, 2026	Insider	Joseph CiaffoniChief Executive Officer	Buy (Option exercise)	1.27M sh		+7.7%	+5.6%	—
Jun 18, 2026	Analyst	Barclays	Reiterates to buy		PT $46	+7.8%	+2.1%	Read
Jun 11, 2026	Insider	Christian HeidbrederChief Scientific Officer	Sell (Open-market sale) 10b5-1	18.59K sh	$707.38K	+0.4%	+5.5%	—
Jun 11, 2026	Insider	Christian HeidbrederChief Scientific Officer	Sell (Open-market sale) 10b5-1	18.59K sh	$707.38K	+0.4%	+5.5%	—

1W / 1M / 6M = how INDV moved from the trade or filing date.

Insider trading in INDV: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Joseph Ciaffoni	Chief Executive Officer	2	—		Jun 22, 2026
Christian Heidbreder	Chief Scientific Officer	2	-$1.41M		Jun 11, 2026

Analyst ratings on INDV

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 18, 2026	Barclays	Reiterates	buy	$46	+7.8%	+2.1%		Read

Frequently asked questions

Are INDV insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 2 open-market sales worth $1.41M, a net -$1.41M.

What is the latest insider trade in INDV?

Joseph Ciaffoni, Chief Executive Officer filed a sell (tax withholding) of 612.55K sh worth $23.47M on Jun 22, 2026.

Other drug manufacturers - specialty & generic stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text